Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients
Objective:Published studies on male breast cancer (MBC) and BRCA mutations are scarce and usually include, a small number of patients. The clinicopathological characteristics of BRCA mutant and wild-type MBC patients were compared in more than forty patients in this study.Materials and Methods:A ret...
Main Authors: | İzzet Doğan, Esra Aydın, Hülya Yazıcı, Pınar Saip |
---|---|
Format: | Article |
Language: | English |
Published: |
Galenos Publishing House
2022-10-01
|
Series: | European Journal of Breast Health |
Subjects: | |
Online Access: |
http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/comparison-of-clinical-pathological-and-prognostic/53091
|
Similar Items
-
BRCA2 Mutations in 154 Finnish Male Breast Cancer Patients
by: Kirsi Syrjäkoski, et al.
Published: (2004-09-01) -
Male BRCA mutation carriers: clinical characteristics and cancer spectrum
by: Mohammed Ibrahim, et al.
Published: (2018-02-01) -
Multifocal breast cancers are more prevalent in BRCA2 versus BRCA1 mutation carriers
by: Alan D McCrorie, et al.
Published: (2020-04-01) -
Turkish population-based screening for first identified changes of BRCA1 and BRCA2 genes in breast and/or ovarian cancer patients
by: Tuğba Semerci Sevimli, et al.
Published: (2024-04-01) -
Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
by: Emiroglu S, et al.
Published: (2023-02-01)